Published in Pharma and Healthcare category by MBA Skool Team
Ranbaxy is one of the leading brands in the pharma and healthcare sector. Ranbaxy SWOT analysis evaluates the brand by its strengths & weaknesses which are the internal factors along with opportunities & threats which are the external factors. Let us start the SWOT Analysis of Ranbaxy:
Top 10 Global Generic Company with a spread over 125 countries
over 13,000 well trained Employees, over 50 nationalities
Strong presence in the International market with a major share and a strong presence in India as well
It has operations in nearly 50 countries and has 7 manufacturing plants
Above are the strengths in the SWOT Analysis of Ranbaxy. The strengths of Ranbaxy looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
It is heavily dependent upon generics for its revenue generation
Constantly regulated policies by the govt means operational efficiency is affected
These were the weaknesses in the Ranbaxy SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Healthcare professionals, wholesalers, generic distributors, and hospitals
A diversifies global healthcare company focused on patient’s needs
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Browse marketing analysis of more brands and companies similar to Ranbaxy. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way. Edit the brand or add a new one to SWOT Analysis section : Contribute